Harmonization Needed For Complex And Value-Added Drugs
As ICH Works Towards Global Harmonization On Generics
Executive Summary
Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.